Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

 


 

FORM 10-Q

 


 

Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended March 31, 2004.

 

Commission file number 1-11834

 


 

UnumProvident Corporation

(Exact name of registrant as specified in its charter)

 


 

Delaware   62-1598430

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

1 FOUNTAIN SQUARE

CHATTANOOGA, TENNESSEE 37402

(Address of principal executive offices)

 

423.755.1011

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2).    Yes  x    No  ¨

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class


 

Outstanding at March 31, 2004


Common stock, $0.10 par value

  296,291,201

 



Table of Contents

TABLE OF CONTENTS

 

          Page

    

Cautionary Statement Regarding Forward-Looking Statements

   1
     PART I     

1.

  

Financial Statements (Unaudited):

    
    

Condensed Consolidated Statements of Financial Condition at March 31, 2004 and December 31, 2003

   3
    

Condensed Consolidated Statements of Operations for the three months ended March 31, 2004 and 2003

   5
    

Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2004 and 2003

   6
    

Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2004 and 2003

   7
    

Notes to Condensed Consolidated Financial Statements

   8
    

Independent Accountants’ Review Report

   27

2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

   28

3.

  

Quantitative and Qualitative Disclosures about Market Risk

   73

4.

  

Controls and Procedures

   73
     PART II     

1.

  

Legal Proceedings

   74

6.

  

Exhibits and Reports on Form 8-K

   74
    

Signatures

   75


Table of Contents

Cautionary Statement Regarding Forward-Looking Statements

 

The Private Securities Litigation Reform Act of 1995 (the Act) provides a “safe-harbor” for forward-looking statements which are identified as such and are accompanied by the identification of important factors that could cause actual results to differ materially from the forward-looking statements. For these statements, UnumProvident Corporation, together with its subsidiaries, unless the context implies otherwise (the Company), claims the protection afforded by the safe harbor in the Act. Certain information contained in this discussion, or in any other written or oral statements made by the Company, is or may be considered as forward-looking. Examples of disclosures that contain such information include, among others, sales estimates, income projections, and reserves and related assumptions. Forward-looking statements are those not based on historical information, but rather relate to future operations, strategies, financial results, or other developments and speak only as of the date made. These statements may be made directly in this document or may be made part of this document by reference to other documents filed with the Securities and Exchange Commission by the Company, which is known as “incorporation by reference.” You can find many of these statements by looking for words such as “may,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “projects,” “goals,” “objectives,” or similar expressions in this document or in documents incorporated herein.

 

These forward-looking statements are subject to numerous assumptions, risks, and uncertainties, many of which are beyond the Company’s control. Factors that may cause actual results to differ materially from those contemplated by the forward-looking statements include, among others, the following factors:

 

  General economic or business conditions, both domestic and foreign, may be less favorable than expected, which may affect premium levels, claims experience, the level of pension benefit costs and funding, and investment results, including credit deterioration of investments.

 

  Competitive pressures in the insurance industry may increase significantly through industry consolidation, competitor demutualization, or otherwise.

 

  Events or consequences relating to terrorism and acts of war, both domestic and foreign, may adversely affect the Company’s business and may also affect the availability and cost of reinsurance.

 

  Legislative, regulatory, or tax changes, both domestic and foreign, may adversely affect the businesses in which the Company is engaged.

 

  Rating agency actions, state insurance department and other enforcement actions, and negative media attention may adversely affect the Company’s business.

 

  The level and results of litigation may vary from prior experience and may adversely affect the Company’s business.

 

  Investment results, including, but not limited to, realized investment losses resulting from impairments, may differ from prior experience and negatively affect results.

 

  Changes in the interest rate environment may adversely affect reserve and policy assumptions and ultimately profit margins and reserve levels.

 

  Sales growth may be less than planned, which could affect revenue and profitability.

 

  Effectiveness in supporting new product offerings and providing customer service may not meet expectations.

 

  Actual experience in pricing, underwriting, and reserving may deviate from the Company’s assumptions.

 

  Actual persistency may be lower than projected persistency, resulting in lower than expected revenue and higher than expected amortization of deferred policy acquisition costs.

 

  Incidence and recovery rates may be influenced by, among other factors, the rate of unemployment and consumer confidence, the emergence of new diseases, new trends and developments in medical treatments, and the effectiveness of risk management programs.

 

  Insurance reserve liabilities may fluctuate as a result of changes in numerous factors, and such fluctuations can have material positive or negative effects on net income.

 

  Retained risks in the Company’s reinsurance operations are influenced primarily by the credit risk of the reinsurers and potential contract disputes. Any material changes in the reinsurers’ credit risk or willingness to pay according to the terms of the contract could have material effects on results.

 

1


Table of Contents

For further discussion of risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” contained in Part 1 of the Company’s Form 10-K for the fiscal year ended December 31, 2003.

 

All subsequent written and oral forward-looking statements attributable to the Company or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. The Company does not undertake any obligation to release publicly any revisions to such forward-looking statements to reflect events or circumstances after the date of this document or to reflect the occurrence of unanticipated events.

 

2


Table of Contents

PART I

 

ITEM 1. FINANCIAL STATEMENTS

 

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION

 

UnumProvident Corporation and Subsidiaries

 

    

March 31

2004

  

December 31

2003

     (in millions of dollars)

     (Unaudited)     

Assets

             

Investments

             

Fixed Maturity Securities - at fair value

             

Available-for-Sale - Continuing Operations

   $ 31,565.9    $ 30,084.2

Available-for-Sale - Discontinued Operations

     1,125.5      1,102.4
    

  

Total Fixed Maturity Securities

     32,691.4      31,186.6

Equity Securities

     43.8      39.1

Mortgage Loans

     460.3      474.7

Real Estate

     26.0      25.9

Policy Loans

     2,877.1      2,877.9

Other Long-term Investments

     78.0      91.9

Short-term Investments

     370.1      332.2
    

  

Total Investments

     36,546.7      35,028.3

Other Assets

             

Cash and Bank Deposits

     131.3      119.2

Accounts and Premiums Receivable

     2,115.5      2,093.5

Reinsurance Receivable

     6,243.7      6,242.6

Accrued Investment Income

     553.7      543.6

Deferred Policy Acquisition Costs

     2,798.8      3,051.9

Value of Business Acquired

     110.4      463.5

Goodwill

     270.0      476.7

Other Assets

     1,346.2      1,336.3

Other Assets - Discontinued Operations

     328.3      330.2

Separate Account Assets

     32.3      32.5
    

  

Total Assets

   $ 50,476.9    $ 49,718.3
    

  

 

See notes to condensed consolidated financial statements.

 

3


Table of Contents

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - Continued

 

UnumProvident Corporation and Subsidiaries

 

    

March 31

2004

   

December 31

2003

 
     (in millions of dollars)

 
     (Unaudited)        

Liabilities and Stockholders’ Equity

                

Liabilities

                

Policy and Contract Benefits

   $ 2,059.1     $ 1,928.4  

Reserves for Future Policy and Contract Benefits and Unearned Premiums

     32,228.8       31,431.1  

Other Policyholders’ Funds

     2,487.6       2,493.3  

Current Income Tax

     35.9       32.8  

Deferred Income Tax

     924.3       914.0  

Long-term Debt

     2,789.0       2,789.0  

Other Liabilities

     1,312.7       1,363.6  

Other Liabilities - Discontinued Operations

     1,472.9       1,462.6  

Separate Account Liabilities

     32.3       32.5  
    


 


Total Liabilities

     43,342.6       42,447.3  
    


 


Commitments and Contingent Liabilities - Note 9

                

Stockholders’ Equity

                

Common Stock, $0.10 par
Authorized: 725,000,000 shares
Issued: 298,242,296 and 298,094,517 shares

     29.8       29.8  

Additional Paid-in Capital

     1,611.4       1,609.1  

Accumulated Other Comprehensive Income

     1,615.5       1,171.2  

Retained Earnings

     3,942.5       4,526.9  

Treasury Stock - at cost: 1,951,095 shares

     (54.2 )     (54.2 )

Deferred Compensation

     (10.7 )     (11.8 )
    


 


Total Stockholders’ Equity

     7,134.3       7,271.0  
    


 


Total Liabilities and Stockholders’ Equity

   $ 50,476.9     $ 49,718.3  
    


 


 

See notes to condensed consolidated financial statements.

 

4


Table of Contents

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

 

UnumProvident Corporation and Subsidiaries

 

    

Three Months Ended

March 31


 
     2004     2003  
     (in millions of dollars,
except share data)


 

Revenue

                

Premium Income

   $ 1,956.2     $ 1,871.3  

Net Investment Income

     534.1       519.3  

Net Realized Investment Gain (Loss)

     25.4       (85.1 )

Other Income

     108.0       89.3  
    


 


Total Revenue

     2,623.7       2,394.8  
    


 


Benefits and Expenses

                

Benefits and Change in Reserves for Future Benefits

     1,879.3       2,143.4  

Commissions

     221.3       221.2  

Interest and Debt Expense

     49.2       41.5  

Deferral of Policy Acquisition Costs

     (148.3 )     (172.7 )

Amortization of Deferred Policy Acquisition Costs

     108.6       114.0  

Amortization of Value of Business Acquired

     3.9       9.8  

Impairment of Intangible Assets

     856.4       —    

Compensation Expense

     187.7       190.6  

Other Operating Expenses

     235.8       236.5  
    


 


Total Benefits and Expenses

     3,393.9       2,784.3  
    


 


Loss from Continuing Operations Before Income Tax Benefit

     (770.2 )     (389.5 )

Income Tax Benefit

     (200.9 )     (140.5 )
    


 


Loss from Continuing Operations

     (569.3 )     (249.0 )

Discontinued Operations - Note 2

                

Income from Operations

     10.8       4.0  

Income Tax Expense

     3.8       1.4  
    


 


Income from Discontinued Operations

     7.0       2.6  
    


 


Net Loss

   $ (562.3 )   $ (246.4 )
    


 


Earnings Per Common Share

                

Basic

                

Loss from Continuing Operations

   $ (1.93 )   $ (1.03 )

Net Loss

   $ (1.91 )   $ (1.02 )

Assuming Dilution

                

Loss from Continuing Operations

   $ (1.93 )   $ (1.03 )

Net Loss

   $ (1.91 )   $ (1.02 )

Dividends Paid

   $ 0.0750     $ 0.1475  

 

See notes to condensed consolidated financial statements.

 

5


Table of Contents

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)

 

UnumProvident Corporation and Subsidiaries

 

     Common
Stock
   Additional
Paid-in
Capital
  

Accumulated

Other

Comprehensive

Income

    Retained
Earnings
    Treasury
Stock
    Deferred
Compensation
    Total  
     (in millions of dollars)

 

Balance at December 31, 2002

   $ 24.4    $ 1,086.8    $ 777.4     $ 5,011.4     $ (54.2 )   $ (2.6 )   $ 6,843.2  

Comprehensive Loss, Net of Tax

                                                      

Net Loss

                           (246.4 )                     (246.4 )

Change in Net Unrealized Gain on Securities

                   (31.9 )                             (31.9 )

Change in Net Gain on Cash Flow Hedges

                   (0.4 )                             (0.4 )

Change in Foreign Currency Translation Adjustment

                   15.4                               15.4  
                                                  


Total Comprehensive Loss

                                                   (263.3 )
                                                  


Common Stock Activity

            0.8                              0.2